» Articles » PMID: 31878023

Metabolic Syndrome-An Emerging Constellation of Risk Factors: Electrochemical Detection Strategies

Overview
Journal Sensors (Basel)
Publisher MDPI
Specialty Biotechnology
Date 2019 Dec 28
PMID 31878023
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Metabolic syndrome is a condition that results from dysfunction of different metabolic pathways leading to increased risk of disorders such as hyperglycemia, atherosclerosis, cardiovascular diseases, cancer, neurodegenerative disorders etc. As this condition cannot be diagnosed based on a single marker, multiple markers need to be detected and quantified to assess the risk facing an individual of metabolic syndrome. In this context, chemical- and bio-sensors capable of detecting multiple analytes may provide an appropriate diagnostic strategy. Research in this field has resulted in the evolution of sensors from the first generation to a fourth generation of 'smart' sensors. A shift in the sensing paradigm involving the sensing element and transduction strategy has also resulted in remarkable advancements in biomedical diagnostics particularly in terms of higher sensitivity and selectivity towards analyte molecule and rapid response time. This review encapsulates the significant advancements reported so far in the field of sensors developed for biomarkers of metabolic syndrome.

Citing Articles

Recent Progress in Transition Metal Dichalcogenides for Electrochemical Biomolecular Detection.

Madhurantakam S, Mathew G, David B, Naqvi A, Prasad S Micromachines (Basel). 2023; 14(12).

PMID: 38138308 PMC: 10745343. DOI: 10.3390/mi14122139.


Towards Multiplexed and Multimodal Biosensor Platforms in Real-Time Monitoring of Metabolic Disorders.

Chu S, Nguyen H, Zhang J, Tabassum S, Cao H Sensors (Basel). 2022; 22(14).

PMID: 35890880 PMC: 9323394. DOI: 10.3390/s22145200.


Biomarkers and Prevalence of Cardiometabolic Syndrome Among People Living With HIV/AIDS, Addis Ababa, Ethiopia: A Hospital-Based Study.

Woldu M, Minzi O, Shibeshi W, Shewaamare A, Engidawork E Clin Med Insights Endocrinol Diabetes. 2022; 15:11795514221078029.

PMID: 35237088 PMC: 8883384. DOI: 10.1177/11795514221078029.


Highly Sensitive Electrochemical Sensor for Diagnosis of Diabetic Ketoacidosis (DKA) by Measuring Ketone Bodies in Urine.

Go A, Park S, Ku Y, Sun M, Yeon S, Lee J Sensors (Basel). 2021; 21(14).

PMID: 34300644 PMC: 8309864. DOI: 10.3390/s21144902.


Serum galectin-3BP as a novel marker of obesity and metabolic syndrome in Chinese adolescents.

Zhen S, Ma Y, Han Y, Zhao Z, Yang X, Wen D BMJ Open Diabetes Res Care. 2021; 9(1).

PMID: 33910911 PMC: 8094345. DOI: 10.1136/bmjdrc-2020-001894.


References
1.
Madhurantakam S, Babu K, Rayappan J, Krishnan U . Fabrication of mediator-free hybrid nano-interfaced electrochemical biosensor for monitoring cancer cell proliferation. Biosens Bioelectron. 2016; 87:832-841. DOI: 10.1016/j.bios.2016.09.039. View

2.
Johnson R, Nakagawa T, Jalal D, Sanchez-Lozada L, Kang D, Ritz E . Uric acid and chronic kidney disease: which is chasing which?. Nephrol Dial Transplant. 2013; 28(9):2221-8. PMC: 4318947. DOI: 10.1093/ndt/gft029. View

3.
Koroshi A . Microalbuminuria, is it so important?. Hippokratia. 2009; 11(3):105-7. PMC: 2658722. View

4.
Laterza O, Price C, Scott M . Cystatin C: an improved estimator of glomerular filtration rate?. Clin Chem. 2002; 48(5):699-707. View

5.
Alberti K, Zimmet P, Shaw J . The metabolic syndrome--a new worldwide definition. Lancet. 2005; 366(9491):1059-62. DOI: 10.1016/S0140-6736(05)67402-8. View